May 18, 2023 / 01:00PM GMT
Robert Blum - Lytham Partners, LLC - Analyst
All right. Hello, everyone, and thank you all for joining us during the Lytham Partners Spring 2023 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners. During this fireside chat, we welcome Lantern Pharma, ticker symbol of LTRN on the Nasdaq, and their CEO, Panna Sharma.
We'll dive into questions in just a moment. But one final reminder, I want to make sure that the management is available for one-on-one meetings later today. If you've not already signed up and would like to do so, you can send me an e-mail, that's Blum, B-L-U-M at lythampartners.com, or you can visit our website, lythampartners.com/virtual, click on the one-on-one meeting request button, and I will look to get you taken care of.
So with that, I will go ahead and get started. So welcome, Panna.
Panna Sharma - Lantern Pharma Inc. - CEO, President & Director
Thank you, Robert. Good to be here.
Lantern Pharma Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
May 18, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers